Kategorie: ‘Pharmaceutical Company News’

Online drug selling is being supervised

April 3rd, 2020 | by

Recently, the National Development and Reform Commission and Ministry of Commerce jointly issued the “Negative List of Market access (2019 version),” which proposed that drug production and trading companies are not allowed to sell prescription drugs directly to the public through mail or internet trade.


来源:制药网 2019.11.23


Improving the supply system of shortage medicines

April 3rd, 2020 | by

Recently, the General Office of the State Council issued the “Guiding Opinions on Maintaining the Price and Supply of Shortage Medicines.” The “Guiding Opinion” stipulated that a national multi-source information collection platform for shortage medicines and a monitoring system for this platform should be established to realise information sharing of APIs (Active Pharmaceutical Ingredient) and pharmaceutical preparations in terms of their registration, production, procurement, and price. As for the drugs in the shortages list, pharmaceutical enterprises are allowed to quote their price on the provincial-level centralised drug procurement platform or on the internet so that medical institutions can purchase them on demand.

国办:强化药品价格常态化监管 完善短缺药品供应体系

来源:医药网 2019.10.14


“Prescription Sharing” supported

April 3rd, 2020 | by

On September 29th, 21 commission and administrations, including the National Development and Reform Commission, the National Healthcare Security Administration, the National Health Commission, the National Medical Product Administration, jointly issued the “Guideline of Promoting a High-quality Development of the Health Industry (2019-2022).” The “Guideline” stipulated that channels for the interconnection and real-time sharing of information on drug consumption and on prescriptions of online diagnosis and treatment should be established nationwide. In the meantime, third-party platforms are suggested to deliver online prescribed drugs to encourage Medical e-commerces to offer “ordering online and delivered offline” services.


来源:医药网 2019.09.30


Nationwide implementation of National Organised Centralised Procurement and Use of Drugs

April 3rd, 2020 | by

On September 24th, 2019, more than 20 provinces and districts all over the country have launched a joint procurement of drugs. Thereby the pilot work on National Organised Centralised Procurement and Use of Drugs is extended from 11 big cities to nationwide. The price of all medicines was lower than the price of selected drugs in “4+7.”


来源:医药网 2019.09.25


Internet Hospital established by Yifeng Pharmacy

April 3rd, 2020 | by

On September 19th, Yifeng Pharmacy announced a joint venture with Visum Pharmaceutical Co., Ltd. to establish Hainan Yifeng Medical Technology Co., Ltd., which aims to provide patients with services such as Internet Hospitals, Prescription Sharing Platform, family doctors, health management, online medical consultations, and patient education.


来源:新浪医药新闻 2019.09.22


The revised “Pharmaceutical Administration Law” allows the online selling of prescription drugs

February 13th, 2020 | by

On August 26th, the revised “Pharmaceutical Administration Law” was approved by the Twelfth Session of the Thirteenth Standing Committee of the National People’s Congress and will come into effect on December 1st, 2019. The “Pharmaceutical Administration Law” proposed that the Marketing Authorisation Holders and pharmaceutical companies can sell drugs online on the premise of complying with relevant provisions. Vaccines, narcotic drugs, and other drugs under special control are not included.


来源:医药网 2019.08.27

8月26日, 新修订版《药品管理法》经十三届全国人大常委会第十二次会议表决通过,并将自2019年12月1日起施行。法案提出,药品上市许可持有人、药品经营企业可在遵守法案关于药品经营的有关规定的前提下通过网络销售药品。疫苗、麻醉药品等国家实行特殊管理的药品不得在网络上销售。

Heilongjiang: The detailed rules of drug price supervision is going to be implemented

February 13th, 2020 | by

On August 9th, the Medical Insurance Bureau of the Heilongjiang province issued the “Notification of Supervising Drug Price and Distribution Information.” The “Notification” stipulates that the supervision of drug price and distribution information should be carried from drug manufacturers, distribution enterprises, medical institutions, retail pharmacies, and public sentiment. The mechanisms for information collection, reporting, analysis, investigation, and processing should be improved at the provincial, city, and county levels.


来源:医药网 2019.08.12


“Drug Evaluation Report in 2018” is released

November 13th, 2019 | by

On July 1st, the National Medical Products Administration(NMPA) issued the “Drug Evaluation Report in 2018.” The “Report” shows that the Drug Evaluation Centre of the NMPA reviewed and approved 106 new drugs in 2018. Although the number of applications for registration of new drugs has increased by 47%, the evaluation time has been reduced significantly in comparison to 2017. Benefiting from the accelerated drug evaluation reforms, the number of applications for registration of innovative drugs has increased significantly in 2018, of which 85% were from domestic companies. At the same time, in order to improve the quality of generic drugs, the Drug Evaluation Centre has made every effort to promote the “Quality Consistency Evaluation for Generic Drugs,” and there were eight batches of generic drugs that are involved in comparison to 2018.


来源:中国医药报 2019.07.01


“Regulation provisions for imported medicinal materials” is released

October 9th, 2019 | by

Recently, the State Administration for Market Regulation issued the modified “Regulation Provision for imported medicinal materials,” which will be implemented on January 1, 2020. The “Provision” stipulates that more medicinal materials should be imported, and the imported medicinal materials should be classified and managed. The management of the imported medicinal material that is not done for the first time should be simplified according to the risk level, thereby reducing the time for examination and approval of imported medicinal materials. When purchasing imported drugs, the regulations of drug traceability should be strictly implemented.


来源:制药网 2019.05.23


Medical insurance designated pharmacies will be incorporated in provincial centralized drug procurement

October 9th, 2019 | by

On May 15th, the Shandong provincial drug purchasing website released a document of “Opinions on the trial implementation of centralized online drug procurement by private pharmaceutical institutions.” The “Opinion” stipulates that private hospitals and chain pharmacies which are managed by the Medical Insurance Protocol should purchase drugs online through the centralized procurement platform of Shandong province, with the total purchase amount not less than 60% of the original usage. The “Opinion” will be implemented on July 1st.


来源:新浪医药新闻  2019.05.17